It was with great pleasure that I assumed the role of Editor-in-Chief (EiC) of GaBI Journal in January of this year. Taking over the helm from Professor Philip D Walson is a considerable challenge; Phil’s excellent, thorough example will be very difficult to follow. My experience is restricted largely to biosimilars with which I have been involved since their concept and I will be relying on able colleagues for their expertise with generics! I hope to be able to carry out the important job of EiC effectively and efficiently.
No takes yet. Share an insight, caveat, or question.
Robin Thorpe (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: